Predicting the in vivo performance of TSPO PET radioligands using a biomathematical modelling approach. - Qi Guo; David R. Owen; Idriss Bennacef; Eugenii A. Rabiner; Christine A. Parker; Michael Brady 001; Roger N. Gunn (NeuroImage, 2010)

Synthesis and in vivo evaluation of [11C]BU99008 as a ligand for the imidazoline I2 binding site. - Steven Kealey; Stephen Husbands; Emma M. Casey; Cristian A. Salinas; Christine A. Parker; Steen Jakobsen; Robin J. Tyacke; David J. Nutt; Antony D. Gee (NeuroImage, 2010)

PBR28, PBR06 and PBR111 bind two distinct TSPO sites in human brain tissue. - David R. Owen; Eugenii A. Rabiner; Roger N. Gunn; Paul M. Matthews; Christine A. Parker (NeuroImage, 2010)

Evaluation of the in vivo ED50 for the PET Radioligand, [11C]GSK-215083, in Papio anubis. - Christine A. Parker; Laurent Martarello; Eugenii A. Rabiner; Roger N. Gunn; Marc Laruelle; Mark Slifstein; Vincent J. Cunningham (NeuroImage, 2010)

New PET tracers for preclinical apoptosis imaging in oncology and CNS applications. - Jean-Frederic Salazar; Carmine Marzano; Görkem Singleton; Christophe Plisson; Christine A. Parker; Vincent J. Cunningham; Laurent Martarello (NeuroImage, 2010)

Effect of cellular compartments on the binding of [3H](+)PhNO to the porcine D2/D3-DAR. - Sarah L. Withey; Roger N. Gunn; Eugenii A. Rabiner; Christine A. Parker (NeuroImage, 2010)